Drug Channels

JULY 21, 2020

pharmacies now participate in the 340B Drug Pricing Program. Below, we update our exclusive analysis of the biggest specialty pharmacies within 340B. As you will see below, these specialty pharmacies have dramatically increased their participation in the 340B program.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Documentation Hospitals 52

Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. Click here to see the original post from April 2024. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Hospitals 52

Drug Channels

NOVEMBER 22, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon Plus, the FDA preps you for Thursday with a regulatory soup review. Happy Thanksgiving, everyone!

Specialty Pharmacies 75

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 75

Drug Channels

APRIL 27, 2021

While we all roll up our sleeves for a full reopening, let’s spring into this month’s selection of noteworthy news: Thoughts on Cigna’s payments to patients for non-medical switching 340B’s explosive specialty pharmacy growth An excellent analysis of GoodRx Plus, my $0.02 drug pricing policy. 3, and more.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Biosimilars 40

Drug Channels

NOVEMBER 9, 2022

Fein will share his latest thinking on a wide range of topics, including: Retail and specialty pharmacy trends Vertical integration and consolidation The Inflation Reduction Act of 2022 The Medicare Part D Redesign Biosimilars Discount cards and cash-pay pharmacies The growing impact of hospitals and health systems The 340B Drug Pricing Program Federal (..)

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 98

pharmaphorum

AUGUST 20, 2020

During that period Teva raised the price from around $17,000 per year to over $73,000 per year, the DoJ alleges. Teva mainly administered the scheme through its specialty pharmacy, Advanced Care Scripts (ACS) with payments amounting to around $300 million during the period, according to the complaint.

Specialty Pharmacies 115

Specialty Pharmacies Drug Pricing 115

Drug Channels

MARCH 8, 2023

Next week, Drug Channels Institute will release our 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. It’s the 14th edition of our popular and comprehensive examination of the entire U.S.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing 98

Drug Channels

MARCH 4, 2025

Emerging controversies, challenges, and threats to watch in the industry And much more! As always, Dr. Fein will clearly distinguish his opinions and interpretations from the objective facts and data.

Specialty Pharmacies 94

Specialty Pharmacies Drug Pricing Labelling 94

Drug Channels

NOVEMBER 23, 2021

Please join me for my upcoming live video webinar, Drug Channels Outlook 2022 , on December 17, 2021, from 12:00 p.m. Happy Thanksgiving, everyone! Before you stretch your stomach, stretch your mind with our extra-stuffed helping of food for thought. to 1:30 p.m.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 40

Drug Channels

NOVEMBER 15, 2021

Fein will share his latest thinking on a wide range of topics, including: The prescription market in 2022 Benefit design and plan sponsor strategies Federal and state drug pricing policy The 340B Drug Pricing Program Consolidation and vertical integration Specialty pharmacy trends Copay accumulators, maximizers, and utilization management tools Biosimilars (..)

Specialty Pharmacies 72

Specialty Pharmacies Drug Pricing Biosimilars 72

Drug Channels

JULY 23, 2020

The stunning growth of specialty pharmacies in the 340B Drug Pricing Program has accelerated a troubling trend: Patients covered by commercial insurance and Medicare Part D are footing the bill for 340B savings. Our indisputable math exposes the little-understood economics behind specialty pharmacies in the 340B program.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

JUNE 12, 2024

Federal grantees are aligned primarily with the vertically intergated organizations' retail pharmacies, while hospitals rely on mail and specialty pharmacies. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D., All rights reserved.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Proxsys Rx

OCTOBER 25, 2024

There are so many ways to optimize your 340B drug program savings and benefits while overcoming manufacturer restrictions. billion in rebates, discounts and fees to insurers, pharmacy benefits managers (PBMs), hospitals, government programs and other healthcare entities. CVS Specialty ( CVS Health ) — $73.3 billion 10.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing 52

Drug Channels

OCTOBER 2, 2024

Federal grantees are aligned primarily with the vertically intergated organizations' retail pharmacies, while hospitals rely on mail and specialty pharmacies. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D., All rights reserved.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

FEBRUARY 22, 2022

On March 15, 2022, Drug Channels Institute will release The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. This 2022 edition addresses COVID-19 and its ongoing impact on the pharmacy and PBM industries.

Specialty Pharmacies 96

Specialty Pharmacies Drug Pricing Biosimilars Vaccines 96

Proxsys Rx

MAY 1, 2023

Court of Appeals for the Third Circuit — which was largely in favor of three drug companies that have imposed harmful limits on safety-net hospitals’ access to 340B drug pricing program discounts. For more information, contact Howard Hall.

Drug Pricing 52

Drug Pricing Hospitals Specialty Pharmacies 52

Proxsys Rx

APRIL 10, 2023

Court of Appeals for the Third Circuit — which was largely in favor of three drug companies that have imposed harmful limits on safety-net hospitals’ access to 340B drug pricing program discounts. For more information, contact Howard Hall.

Drug Pricing 52

Drug Pricing Hospitals Specialty Pharmacies 52

Drug Channels

FEBRUARY 21, 2023

On March 14, 2023, Drug Channels Institute will release The 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. This report—our fourteenth edition—remains the most comprehensive, fact-based tool for understanding the entire U.S.

Specialty Pharmacies 97

Specialty Pharmacies Drug Pricing Biosimilars 97

Proxsys Rx

DECEMBER 11, 2023

At the same time, it’s no secret that, since the advent of 340B ESP in 2020, the drug manufacturers have imposed a raft of restrictions on 340B program savings that exist far outside the letter of the law as written by Congress in 1992. Every specialty pharmacy patient you serve should be monitored by a clinic pharmacist.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Labelling 52

Drug Channels

MARCH 15, 2022

Pharmacies and Pharmacy Benefit Managers , our 13th edition, provides a comprehensive, fact-based, and non-partisan tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system. The 2022 Economic Report on U.S. The chart below illustrates the depth and breadth of the 2022 edition.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

Putting Patients First Blog

NOVEMBER 14, 2023

NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program (PDF) November 13, 2023 Benjamin Stidham, Contract Specialist Centers for Medicare & Medicaid Services U.S. Pharmacy benefit managers: transparency, accountability, and impact on patient care.

Drug Pricing 40

Drug Pricing Specialty Pharmacies HIPAA Payment Processing 40

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. As you will see below, mail and specialty pharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Hospitals 40

Drug Channels

MARCH 31, 2021

P.S. Join the more than 11,400 followers of my daily links to neat stuff at @DrugChannels on Twitter.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing 40

Proxsys Rx

MARCH 1, 2024

At the same time, it’s no secret that, since the advent of 340B ESP in 2020, the drug manufacturers have imposed a raft of restrictions on 340B program savings that exist far outside the letter of the law as written by Congress in 1992. Every specialty pharmacy patient you serve should be monitored by a clinic pharmacist.

Specialty Pharmacies 40

Specialty Pharmacies Hospitals Drug Pricing Labelling 40

Drug Channels

FEBRUARY 23, 2021

Let’s melt away this foul February with our monthly selection of scorching news from around the drug channel. In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar!

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Independent Pharmacies Online Pharmacies 52

Drug Channels

JUNE 24, 2021

Next week, Drug Channels Institute will release our 2021 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 12th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. You can preorder at special discounted prices.).

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing 40

Drug Channels

JULY 6, 2020

Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 11th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. prescription dispensing revenues for calendar year 2019.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing 40

Drug Channels

JULY 6, 2020

Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 11th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. prescription dispensing revenues for calendar year 2019.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing 40

Drug Channels

APRIL 19, 2021

Join the compliance community for dynamic discussions on the top risk areas for specialty pharmaceutical companies, including speaker programs, patient support programs, charitable donations, specialty pharmacy relationships, patient advocacy group interactions, mergers and acquisitions, medical affairs activities, drug pricing, transparency and more! (..)

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 40

Proxsys Rx

APRIL 19, 2024

HRSA issues “Administrative Dispute Resolution” ruling On April 19, HRSA issued a ruling entitled “340B Drug Pricing Program; Administrative Dispute Resolution.” Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Packaging 52

Drug Channels

MARCH 9, 2021

Next week, Drug Channels Institute will release our 2021 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 12th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. You can preorder at special discounted prices.).

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing 40

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). Pharmacy benefit managers: transparency, accountability, and impact on patient care. Casalino, L.,

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Proxsys Rx

JANUARY 12, 2024

Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering. Some covered entities generate as much as 600% in revenue from 340B specialty drugs as they do in traditional retail / outpatient pharmacy 340B prescriptions.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Packaging 52

Drug Channels

APRIL 11, 2021

Drug Channels readers save 10% off the current registration rate with promo code 21PSSDC10.* Register today.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing 40

HealthPartners

JULY 21, 2021

We negotiate the lowest pricing in our network of retail pharmacies, mail order pharmacy and specialty pharmacy partnerships. Excellent member experience It’s hard to lower your pharmacy costs if your members aren’t getting adequate support to follow their therapies correctly and start feeling better.

Biosimilars 52

Biosimilars Specialty Pharmacies Mail-Order Pharmacies Health Insurance Companies 52

Ramblings of a pharmacist

FEBRUARY 16, 2022

I presume that their fill-at-specialty-pickup-at-retail program counts these rx revenues in the specialty pharmacy division. rx - they don't appear to report their specialty pharmacies as a separate division. Compare Walgreens as well , page 45 of their 10-k shows $107701M/818M rxs = $131.66/rx

Independent Pharmacies 52

Independent Pharmacies Compounding Specialty Pharmacies Prescription Filling 52

Putting Patients First Blog

JANUARY 27, 2025

Consequences of Obesity, last reviewed May 15, 2023, [link] www.cdc.gov/obesity/basics/consequences.html 6 Libbi Green and Patty Taddei-Allen, “Shifting Paradigms: Reframing Coverage of Antiobesity Medications for Plan Sponsors,” Journal of Managed Care & Specialty Pharmacy 29, no. 14 National Health Council.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40